These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 6123701)

  • 1. Beta-adrenoceptor agonists and obstructive airways disease.
    Basran GS; Morley J; Paul W
    Lancet; 1982 Jun; 1(8286):1412-3. PubMed ID: 6123701
    [No Abstract]   [Full Text] [Related]  

  • 2. Drug strategies for airflow obstruction.
    Petty TL
    Am J Nurs; 1987 Feb; 87(2):180-4. PubMed ID: 2880508
    [No Abstract]   [Full Text] [Related]  

  • 3. Chronic obstructive pulmonary disease: new opportunities for drug development.
    Barnes PJ
    Trends Pharmacol Sci; 1998 Oct; 19(10):415-23. PubMed ID: 9803832
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Corticosteroids and adrenoceptor agonists: the compliments for combination therapy in chronic airways diseases.
    Sin DD; Man SF
    Eur J Pharmacol; 2006 Mar; 533(1-3):28-35. PubMed ID: 16457807
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Theophylline is no more obsolete than "two puffs qid" of current beta 2 agonists.
    Jenne JW
    Chest; 1990 Jul; 98(1):3-4. PubMed ID: 1972917
    [No Abstract]   [Full Text] [Related]  

  • 6. [Beta-2 agonists in the therapy of obstructive airway diseases].
    Solèr M
    Praxis (Bern 1994); 1996 Sep; 85(38):1159-61. PubMed ID: 8927893
    [No Abstract]   [Full Text] [Related]  

  • 7. [Therapy with beta adrenergic agents].
    Russi EW
    Schweiz Rundsch Med Prax; 1986 Jan; 75(5):94-7. PubMed ID: 2869565
    [No Abstract]   [Full Text] [Related]  

  • 8. Long acting beta(2) agonists and theophylline in stable chronic obstructive pulmonary disease.
    Cazzola M; Donner CF; Matera MG
    Thorax; 1999 Aug; 54(8):730-6. PubMed ID: 10413727
    [No Abstract]   [Full Text] [Related]  

  • 9. Effects of beta-adrenergic agents on hypokalemia.
    Raimondi G; Rodriguez-Moncalvo JJ
    Chest; 1987 Feb; 91(2):288-9. PubMed ID: 2879708
    [No Abstract]   [Full Text] [Related]  

  • 10. [Therapy of bronchiolar obstruction with special reference to beta-adrenergic drugs].
    Cornia G; Gramiccioni E
    Minerva Med; 1976 Apr; 67(17):1110-4. PubMed ID: 4757
    [No Abstract]   [Full Text] [Related]  

  • 11. The use of bronchodilators in stable chronic obstructive pulmonary disease.
    Cazzola M; Spina D; Matera MG
    Pulm Pharmacol Ther; 1997 Jun; 10(3):129-44. PubMed ID: 9514624
    [No Abstract]   [Full Text] [Related]  

  • 12. [Long-acting beta-2 adrenergic agents--a new therapeutic tool in COBP].
    Mihălţan F; Ulmeanu R
    Pneumoftiziologia; 1996; 45(3-4):183-4. PubMed ID: 9221046
    [No Abstract]   [Full Text] [Related]  

  • 13. [Preventive therapy essential in the treatment of patients with COPD].
    Postma DS; Quanjer PH
    Ned Tijdschr Geneeskd; 1992 Mar; 136(10):455-60. PubMed ID: 1347646
    [No Abstract]   [Full Text] [Related]  

  • 14. [Use of delayed-action beta-2 mimetics in the management of chronic obstructive bronchial disease--against].
    Terrioux P
    Rev Mal Respir; 1999 Jan; 16 Suppl 3():S76-7. PubMed ID: 10088258
    [No Abstract]   [Full Text] [Related]  

  • 15. [Use of delayed-action beta-2 mimetics in the management of chronic obstructive bronchial diseases--for].
    Muir JF; Cuvelier A
    Rev Mal Respir; 1999 Jan; 16 Suppl 3():S75-6. PubMed ID: 10088257
    [No Abstract]   [Full Text] [Related]  

  • 16. [Bronchodilators: beta-sympathicomimetics].
    van Herwaarden CL
    Ned Tijdschr Geneeskd; 1986 Oct; 130(42):1876-8. PubMed ID: 2878376
    [No Abstract]   [Full Text] [Related]  

  • 17. [New beta-adrenergic receptor stimulators in the symptomatic treatment of asthma and chronic obstructive bronchial diseases].
    Van Der Straeten M; Lamont H; Pauwels R; Tasson J
    Acta Tuberc Pneumol Belg; 1974; 65(3-4):384-94. PubMed ID: 4156900
    [No Abstract]   [Full Text] [Related]  

  • 18. [Treatment of chronic obstructive bronchopathies].
    Pariente R
    Rev Prat; 1985 May; 35(25):1509-12. PubMed ID: 2860717
    [No Abstract]   [Full Text] [Related]  

  • 19. [Therapy of obstructive respiratory tract diseases. I: Beta 2-sympathomimetic drugs and anticholinergic agents (m-cholinergic receptor blockers)].
    Ukena D; Schlimmer P; Sybrecht GW
    Med Klin (Munich); 1989 Jun; 84(6):294-302. PubMed ID: 2569161
    [No Abstract]   [Full Text] [Related]  

  • 20. [The place of long-acting beta 2 adrenergic agonists in the treatment of asthma and chronic obstructive pulmonary disease].
    Bootsma GP; Van Weel C; Van Herwaarden CL
    Ned Tijdschr Geneeskd; 1999 Apr; 143(14):764. PubMed ID: 10347634
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.